by Backoffice | Nov 3, 2023 | Studies and testing
The first two children with autism spectrum disorder (ASD) and signs of leaky gut syndrome were treated October 2023 with allogeneic adipose-derived mesenchymal stem cells (C2C_ASCs) at Aalborg University Hospital without any complication. The project is a...
by Backoffice | Apr 18, 2023 | Studies and testing
Patient with severe terminal lung disease may ultimately be treated with a donor lung transplantation. However, transplantation of a lung from another person elicits a strong immunologic reaction by the recipient towards the transplanted donor lung. In the worst case,...
by Backoffice | Feb 9, 2023 | Studies and testing
The first patient with diabetic foot ulcer was treated with Cell2Cure’s allogeneic adipose tissue-derived mesenchymal stromal cell product (C2C_ASCs) January 24, 2023 at Bispebjerg University Hospital, Copenhagen, Denmark. The STEMFOOT study is carried out in...
by Backoffice | Nov 4, 2022 | Studies and testing
The Danish National Center for Ethics has November 2nd, 2022, approved the un-blinded phase I clinical trial with dose-titrating of allogeneic adipose-derived mesenchymal stem cells (ASCs) for treatment of children with autism. The project is a collaboration between...
by Backoffice | Sep 21, 2022 | Studies and testing
Cell2Cure will be investigating treatment of patients with diabetic foot ulcus with C2C_ASC. The clinical study will be carried out in collaboration with Professor Ole Lander Svendsen and his team at Bispebjerg University Hospital, Copenhagen, Denmark. The study was...
by Backoffice | Jun 17, 2022 | Studies and testing
Aqueous Deficient Dry Eye Disease, Sjögren’s syndrome is a serious autoimmune disease that can cause serious eye and vision problems due to reduced tear production. The patient enrollment is now finalized in the randomized double-blind placebo-controlled phase II...
